M

Matthew Milim

About

Detail

Chief Executive Officer
New York, United States

Timeline


work
Job
school
Education

Résumé


Jobs verified_user 0% verified
  • Libra Solutions
    Chief Executive Officer
    Libra Solutions
    Jan 2023 - Current (3 years 6 months)
    Libra Solutions is the nation's leading provider of consumer legal funding solutions to plaintiffs, attorneys and medical providers. Through the Oasis brand, provides consumer legal funding on a non-recourse basis to personal injury victims pursuing predictable legal claims, primarily arising out of auto accidents and work injuries. Through the MoveDocs brand provides a technology platform used by thousands of law offices and medical providers used to create efficiencies when managing plaintiff personal injury cases. Through the Probate Advance brand, provides inheritance funding solutions to beneficiaries of decedents estates.
  • Libra Solutions
    Member Board of Directors
    Libra Solutions
    Dec 2022 - Current (3 years 7 months)
  • N
    Councilman
    NORTH CASTLE TOWN OF INC
    Jan 2022 - Current (4 years 6 months)
    Elected official (Councilman) on the Town Board of North Castle, NY.
  • Probate Advance LLC
    Founder and CEO
    Probate Advance LLC
    Sep 2018 - Dec 2022 (4 years 4 months)
    We provide inheritance advances to beneficiaries in probate cases
  • Citadel LLC
    Portfolio Manager
    Citadel LLC
    Mar 2013 - Jul 2018 (5 years 5 months)
  • S
    Analyst
    Seneca Capital
    Dec 2005 - Mar 2013 (7 years 4 months)
  • Credit Suisse First Boston
    Analyst
    Credit Suisse First Boston
    Dec 2003 - Dec 2005 (2 years 1 month)
    Mergers and acquisitions and other general advisory assignments in the utilities space
  • Dresdner Kleinwort
    Analyst
    Dresdner Kleinwort
    Jul 2003 - Dec 2003 (6 months)
Education verified_user 0% verified
  • Cornell University
    Bachelor of Science (BS, Applied Economics and Management
    Cornell University
    Jan 1999 - Dec 2003 (5 years)
This is a community-created genome.